Quadruplet in vitro fertilization pregnancy complicated by fetal reduction and leiomyoma

A woman had a quadruplet IVF pregnancy with a leiomyomatous uterus. Pregnancy resulted in the birth of one baby after missed abortion of one fetus and selective reduction of two others. The woman had a left deep calf vein thrombosis in the first half of pregnancy.     

MRI评估子宫肌瘤患者行腹腔镜下肌瘤剔除术的可行性

目的探讨MRI评估子宫肌瘤患者行腹腔镜下肌瘤剔除术的可行性。方法回顾性分析2019年1月至2019年12月于我院收治的60例子宫肌瘤患者临床资料,根据2011年FIGO新的子宫肌瘤分类标准对子宫肌瘤分类,测量子宫肌瘤大小及数目,按照临床及腹腔镜下子宫肌瘤剔除术的适应症标准,筛选符合腹腔镜下子宫肌瘤剔除术的病例,计算MRI对腹腔镜下子宫肌瘤剔除术的排除率、手术率。结果本研究中60例患者经MRI检查,病灶单发者19例,多发者41例,子宫肌瘤病灶数目共计119个,其中112个位于子宫体,5个位于子宫颈,阔韧带2个;其中6-7型子宫肌瘤55个,3-5型子宫肌瘤48个,0-2型子宫肌瘤5个,混合型6个,特殊类型5个。最终符合腹腔镜下子宫肌瘤剔除术手术标准者25例,排除者35例,手术率为41.67%,排除率为58.33%。结论MRI能对子宫肌瘤患者行腹腔镜下肌瘤剔除术的可行性进行评估,筛选适宜手术的患者,且能为临床医师行腹腔镜下肌瘤剔除术提供影像学基础。     

腹腔镜下核除子宫肌瘤后两种缝合方法的临床探讨

目的研究分析采用两种缝合方法对于腹腔镜下核除子宫肌瘤的临床治疗效果。方法该择该院2011年12月—2013年12月收治140例子宫肌瘤患者作为研究对象,将所有患者按照随机数字法分为观察组和对照组两组,每组各70例。对照组患者在摘除肌瘤之后采用间断缝合术,观察组患者采取连续缝合子宫术。对比观察两组患者在手术时间、术中出血量、疼痛恢复时间、出院时间以及排气时间情况的比较。结果观察组患者在手术时间、术中出血量以及疼痛恢复时间均明显短于对照组,差异有统计学意义（P〈0.05）。两组患者在出血时间、排气时间情况的差异无统计学意义（P〉0.05）。结论对于腹腔镜下核除子宫肌瘤后采取连续缝合子宫术能够有效缩短手术时间,降低术中出血量,值得临床推广运用。     

剖宫产术中子宫肌瘤剥除术81例分析

目的探讨剖宫产同时行子宫肌瘤剥出术的安全性和可行性。方法回顾性分析81例剖宫产同时行子宫肌瘤剥除术患者(研究组)的临床资料,观察其手术时间、术中出血量、产后出血量、术后病率、住院时间等情况,并与同期81例行单纯剖宫产的患者(对照组)进行对比分析。结果研究组手术操作时间较对照组延长,差异有统计学意义(P0.05),但两组的术中出血量、产后出血量、术后病率、术后住院天数比较,差异均无统计学意义(P0.05)。结论根据患者的具体情况,选择性地行剖宫产同时子宫肌瘤剥除术是安全可行的;但肌瘤直径≥8cm或子宫肌瘤数目超过5个时,要做好充分的术前准备,以保证手术的安全。     

A Comparison of Single-, Two- and Three-Port Laparoscopic Myomectomy

Background and Objective:

A recent FDA safety communication has discouraged the use of a power morcellator for myoma extraction and has called for a change in surgical techniques for myomectomy. The objective of this study was to compare surgical outcomes of laparoscopic single-, two-, and conventional three-port myomectomy and to evaluate the feasibility of contained manual morcellation for uterine myoma.

Methods:

This retrospective study was a review and analysis of data from 191 consecutive women who underwent single-, two-, or three-port myomectomy for the management of uterine myoma from January 1, 2009, through December 31, 2014.

Results:

The 3 study groups did not differ demographically. Apart from operative time, the single- and two-port groups showed operative outcomes comparable to those of the multiport group. The single-port group had significantly longer operative times (P = .0053) than the two- and three-port groups. However, in the latter half of the single-port cases, the operative time was similar to those in the three-port group. The two-port surgery group showed a consistent operative time without a learning period.

Conclusion:

Single- or two-port myomectomy with transumbilical myoma morcellation is feasible and safe, with outcomes comparable to those of three-port myomectomy. These results suggest the potential for minimally invasive management of symptomatic uterine myoma, without the use of a power morcellator.     

Comparison of Robotic,Laparoscopic, and Abdominal Myomectomy in a Community Hospital

Background and Objectives:

To evaluate the operative outcomes between robotic, laparoscopic, and abdominal myomectomies performed by a private gynecologic oncology practice in a suburban community hospital.

Methods:

The medical records of 322 consecutive robotic, laparoscopic, and abdominal myomectomies performed from January 2007 through December 2009 were reviewed. The outcomes were collected from a retrospective review of patient medical records.

Results:

Records for 14/322 (4.3%) patients were incomplete. Complete data were available for 308 patients, including 169 (54.9%) abdominal, 73 (23.7%) laparoscopic, and 66 (21.4%) robotic-assisted laparoscopic myomectomies. Patients were similar in age, body mass index, parity, and previous abdominopelvic surgery. Median operative time for robotic surgery (140 min) was significantly longer (P<.005) compared to laparoscopic (70 min) and abdominal (72 min) myomectomies. Robotic and laparoscopic myomectomies had significantly less estimated blood loss and hospital stay compared to abdominal myomectomies. There was no significant difference in complications or in the median size of the largest myoma removed between the different modalities. However, the median aggregate weight of myomas removed abdominally (200g; range, 1.4 to 2682) was significantly larger than that seen laparoscopically (115g; range, 1 to 602) and robotically (129g; range 9.4 to 935). Postoperative transfusion was significantly less frequent in robotic myomectomies compared to laparoscopic and abdominal myomectomies.

Conclusion:

While robotic-assisted laparoscopic myomectomies had longer operative times, laparoscopic and robotic-assisted laparoscopic myomectomies demonstrated shorter hospital stays, less blood loss, and fewer transfusions than abdominal myomectomies. Robotic myomectomy offers a minimally invasive alternative for management of symptomatic myoma in a community hospital setting.     

Postoperative Outcomes After Robotic Versus Abdominal Myomectomy

Background and Objectives:

Differences in postoperative outcomes comparing robotic-assisted laparoscopic myomectomy (RALM) with abdominal myomectomy (AM) have rarely been reported. The objective of this study was to compare surgical, quality-of-life, and residual fibroid outcomes after RALM and AM.

Methods:

Consecutive patients who underwent RALM (n = 16) were compared with AM patients (n = 23) presenting with a uterine size of <20 weeks. Study patients participated in a telephone interview at 6 weeks and underwent a no-cost ultrasonographic examination at 12 weeks after surgery to obtain quality-of-life and residual fibroid outcomes. Medical records were reviewed to obtain surgical outcomes.

Results:

Longer operative times (261.1 minutes vs 124.8 minutes, P < .001) and a 3-fold unfavorable difference in operative efficiency (73.7 g vs 253.0 g of specimen removed per hour, P < .05) were observed with RALM compared with AM. Patients undergoing RALM had shorter lengths of hospital stay (1.5 days vs 2.7 days, P < .001). Reduction of patient symptoms and overall satisfaction were equal. RALM patients were more likely to be back to work within 1 month (85.7% vs 45.0%, P < .05). Residual fibroid volume in the RALM group was 5 times greater than that in the AM group (17.3 cm³ vs 3.4 cm³, P < .05).

Conclusion:

RALM and AM were equally efficacious in improving patient symptoms. Although operative times were significantly longer with RALM, patients had a quicker recovery, demonstrated by shortened lengths of stay and less time before returning to work. However, greater residual fibroid burden was observed with RALM when measured 12 weeks after surgery.